Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Nilotinib + Radiation for Chordoma
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial is testing a drug, nilotinib, to see if it can help shrink tumors when used with radiation therapy. Researchers want to see if it is safe and what the highest dose is that can be given without causing severe side effects.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service